VuComp received U.S. Food and Drug Administration (FDA) premarket approval (PMA) of the M-Vu CAD Version 3 system for digital mammography. This generation of CAD technology intends to lower false positive rates. The company upgraded all M-Vu users’ systems with M-Vu CAD Version 3 at no charge.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now